Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
Official title: The DBCG RT Natural Trial: Partial Breast Versus no Irradiation for Women >=60 Years Operated With Breast Conservation for an Early Breast Cancer: a Clinically Controlled Randomized Phase III Trial
Status: Recruiting now
Description:
All early breast cancer patients are offered adjuvant breast radiation therapy (RT) after breast conserving surgery for an early breast cancer. Breast cancer is heterogeneous, and selected patients have a very low gain from RT, whilst they still have risk of acute and late side effects from RT. This trial will try identify selection criteria for low risk breast cancer patients who can safely omit adjuvant RT without unacceptable high risk of local failure.
What is being studied: radiation — No partial breast irradiation.
Who can take part: ages 60 Years, sex: female, 926 participants planned.
Enrollment status: Open now. The study started 05 September 2018 and is expected to finish 01 September 2035.
Contact: Birgitte V Offersen, PhD, +45 28838012, bvo@oncology.au.dk.
Source: ClinicalTrials.gov, NCT03646955 (https://clinicaltrials.gov/study/NCT03646955).
Start date: September 05, 2018
Completion date: September 01, 2035
Organizer: Danish Breast Cancer Cooperative Group
Contact: Birgitte V Offersen, PhD
Tel.: +45 28838012
Email: bvo@oncology.au.dk
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- What is vitiligo?
Vitiligo (pronounced vit-ill-EYE-go) is a generally unpredictable skin disease that causes a gradual loss of skin color and overlying hair on different parts of the body. Contr...
- Isn't it just a cosmetic disorder?
Contrary to popular belief, vitiligo is not merely a cosmetic issue but a complex autoimmune disorder that affects the body’s largest organ—along with other vital systems—and is...
- Does halo nevi affect vitiligo development?
Halo nevi (also known as Sutton's nevi) are characterized by a mole that's surrounded by a ring of depigmented or lighter skin. While both halo nevi and vitiligo involve the des...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.